Skip to main navigation Skip to search Skip to main content

Bone marrow biopsy in patients with malignant neoplasms other than lymphomas or leukemia

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

104 patients with various cancers, excluding malignant lymphoma and leukemia, underwent bone marrow biopsy using a Jamshidi needle, regular type. In 100 patients an adequate piece of bone marrow was obtained. In 24 patients metastases were detected in the bone marrow. Metastases were found in 10 of 38 (26.3%) patients with breast cancer, in 5 of 17 (29.44%) patients with lung cancer, in 5 of 10 (50%) patients with cancer of the prostate, in I patient with rhabdomyosarcoma, 1 with chordoma and in 2 of 14 patients who underwent biopsy in search of unknown cancer. 71% of the patients with positive findings in the bone marrow had clinical signs of bone involvement, 80% had positive X-ray film and 78.9% had positive skeletal isotope survey. Hemogram, serum alkaline phosphatase, serum calcium level and sedimentation rate were of no value in predicting whether the marrow was involved or not. No complications were documented following biopsy. The use of the Jamshidi bone marrow biopsy needle for staging and early detection of metastases in a select group of cancer patients is suggested.

Original languageEnglish
Pages (from-to)181-184
Number of pages4
JournalActa Haematologica
Volume62
Issue number4
DOIs
StatePublished - 1 Jan 1979
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Biopsy
  • Bone marrow
  • Malignant neoplasm

ASJC Scopus subject areas

  • Hematology

Fingerprint

Dive into the research topics of 'Bone marrow biopsy in patients with malignant neoplasms other than lymphomas or leukemia'. Together they form a unique fingerprint.

Cite this